Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 237.00
Bid: 235.00
Ask: 237.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.851%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 237.00
PCA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Palace Capital (PCA): Strong trading update

22 Apr 2021 16:40

Hardman & Co Research Hardman & Co Research: Palace Capital (PCA): Strong trading update 22-Apr-2021 / 16:40 GMT/BST


Hardman & Co Research: Strong trading update

December 2020 quarter rents showed 92% received; as of the 14 April trading update, 82% of the rents due end-March under the monthly payment plans had been received - a good initial profile. Hudson Quarter (HQ) sales are progressing well into a robust market, and the leisure assets have seen several new lettings. It is also encouraging to see ongoing small, non-core disposals at above book. In addition, cash and facility headroom are more than adequate, at £14.4m, and the company's strategy and its execution remain attractive after the test of COVID-19. The largest segment is regional offices, and there is a positive upside opportunity here for 2021, we believe.

Please click on the link below for the full report:

https://www.hardmanandco.com/research/corporate-research/strong-trading-update/

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Mike Foster

+44(0)20 3693 7075

 

mf@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1187869 22-Apr-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
30th Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20232:30 pmRNSHolding(s) in Company
21st Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 20237:00 amRNSDividend Declaration
14th Feb 20237:00 amRNSIndustrial property disposal
6th Feb 20237:00 amRNSShare Buyback
22nd Dec 20227:00 amRNSDisposals and Debt Position Update
25th Nov 20224:40 pmRNSSecond Price Monitoring Extn
25th Nov 20224:35 pmRNSPrice Monitoring Extension
24th Nov 20227:00 amRNSInterim Results
20th Oct 202212:03 pmRNSDirector Dealing
18th Oct 20223:49 pmRNSHolding(s) in Company
12th Oct 20227:00 amRNSTrading Update
15th Sep 20227:00 amRNSDividend Declaration
18th Aug 20222:51 pmRNSDirector Dealing
12th Aug 20227:00 amRNSBoard change
2nd Aug 20227:00 amRNSBoard change
29th Jul 20223:18 pmRNSResult of AGM
28th Jul 20221:39 pmRNSHolding(s) in Company
20th Jul 20226:04 pmRNSDirector Dealing
19th Jul 20227:00 amRNSFurther Update on Strategy and Changes to Board
15th Jul 20224:27 pmRNSHolding(s) in Company
13th Jul 202211:58 amRNSHolding(s) in Company
12th Jul 20223:36 pmRNSHolding(s) in Company
12th Jul 20229:50 amRNSHolding(s) in Company
12th Jul 20227:00 amRNSTransaction in Own Shares
4th Jul 20227:01 amRNSCommencement of share buyback
4th Jul 20227:00 amRNSUpdate on Strategy
28th Jun 202210:27 amRNSAnnual Report and Notice of Annual General Meeting
14th Jun 20222:10 pmRNSDividend Declaration
14th Jun 20227:01 amRNSResults for the year ended 31 March 2022
14th Jun 20227:00 amRNSBoard Change
1st Jun 20225:04 pmRNSTotal Voting Rights
6th Apr 20227:00 amRNSTrading update and dividend increase
25th Mar 20229:10 amRNSHolding(s) in Company
16th Mar 20223:58 pmRNSHolding(s) in Company
15th Mar 20222:03 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSDividend Declaration and Market Update
14th Mar 20229:46 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPalace Capital exceeds disposal strategy targets
20th Jan 20224:40 pmRNSSecond Price Monitoring Extn
20th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSAcquisition of Maidenhead office building
20th Dec 20217:00 amRNSDisposal strategy nears completion
16th Dec 20217:00 amRNSAppointment of new Chairman
15th Dec 202110:46 amEQSHardman & Co Research: Hardman & Co Video | Analyst interview Q&A with Mike Foster on Palace Capital (PCA) | Interim results - ammunition for major dividend rises
9th Dec 20217:00 amRNSLetting of office space at Hudson Quarter, York
6th Dec 20217:00 amRNSSale of Staines Office Building
3rd Dec 202112:40 pmEQSHardman & Co Research : Palace Capital (PCA) - Interim results: ammunition for major dividend rises
29th Nov 20217:00 amRNSDisposal strategy continues with Aldershot sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.